Burzynski Research Institute (Burzynski Research Institute) Days Inventory : 0.00 (As of Feb. 2024)

View and export this data going back to . Start your Free Trial

What is Burzynski Research Institute Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Burzynski Research Institute's Average Total Inventories for the three months ended in Feb. 2024 was $0.00 Mil. Burzynski Research Institute's Cost of Goods Sold for the three months ended in Feb. 2024 was $0.00 Mil.

The historical rank and industry rank for Burzynski Research Institute's Days Inventory or its related term are showing as below:

BZYR's Days Inventory is not ranked ^*
in the Biotechnology industry.
Industry Median: 192.72
* Ranked among companies with meaningful Days Inventory only.

Burzynski Research Institute's Days Inventory stayed the same from Feb. 2023 (0.00) to Feb. 2024 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Burzynski Research Institute Days Inventory Historical Data

The historical data trend for Burzynski Research Institute's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Burzynski Research Institute Days Inventory Chart

Burzynski Research Institute Annual Data

Trend

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Days Inventory

Get a 7-Day Free Trial

Burzynski Research Institute Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Days Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Burzynski Research Institute's Days Inventory

For the Biotechnology subindustry, Burzynski Research Institute's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Burzynski Research Institute's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Burzynski Research Institute's Days Inventory distribution charts can be found below:

* The bar in red indicates where Burzynski Research Institute's Days Inventory falls into.

Burzynski Research Institute Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Burzynski Research Institute's Days Inventory for the fiscal year that ended in Feb. 2024 is calculated as

	Days Inventory (A: Feb. 2024 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Feb. 2023 )	+	Total Inventories (A: Feb. 2024 ))	/	count )	/	Cost of Goods Sold (A: Feb. 2024 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

Burzynski Research Institute's Days Inventory for the quarter that ended in Feb. 2024 is calculated as:

	Days Inventory (Q: Feb. 2024 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Nov. 2023 )	+	Total Inventories (Q: Feb. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Feb. 2024 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 4
=	0					/	0	*	365 / 4
=	N/A

Burzynski Research Institute (OTCPK:BZYR) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Burzynski Research Institute's Inventory Turnover for the three months ended in Feb. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0
	=

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Burzynski Research Institute's Inventory to Revenue for the three months ended in Feb. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0
	=

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Burzynski Research Institute Days Inventory Related Terms

Thank you for viewing the detailed overview of Burzynski Research Institute's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Burzynski Research Institute (Burzynski Research Institute) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Burzynski Research Institute Inc (OTCPK:BZYR) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

9432 Katy Freeway, Houston, TX, USA, 77055

Website

http://www.burzynskiresearch.com

Burzynski Research Institute Inc engages in the research, production, marketing, promotion, and sale of certain medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives and organic acids which are known under the trade name Antineoplastons. Antineoplastons are used in the treatment of human cancer. Its pipeline development programs of the company include clinical trials for the treatment of a wide variety of cancers using only a combination of Antineoplastons A10 and AS2-1.

Executives

Monika Szopa-paszkowiak	director	9432 KATY FWY #200, HOUSTON TX 77055
Frederick Richard Schiff	director	9432 KATY FREEWAY, HOUSTON TX 77055
Barbara Burzynski	director, 10 percent owner	9432 KATY FREEWAY, HOUSTON TX 77055
Carlton Hazlewood	director	9432 KATY FREEWAY, HOUSTON TX 77055
Patryk Goscianski	officer: Secretary and Treasurer	9432 KATY FREEWAY, HOUSTON TX 77055
Gregory Burzynski	director	9432 KATY FREEWAY, HOUSTON TX 77055
Tomasz Janicki	officer: VP of Clinical Trials	9432 KATY FREEWAY, HOUSTON TX 77055
Michael Driscoll	director	9432 KATY FREEWAY, HOUSTON TX 77055
Stanislaw Burzynski	director, 10 percent owner, officer: President	9432 KATY FREEWAY, HOUSTON TX 77055
Dudley Reece Anderson	officer: Chief Financial Officer	9432 OLD KATY RD., SUITE 200, HOUSTON TX 77055

Burzynski Research Institute (Burzynski Research Institute) Headlines

No Headlines